Publication | Open Access
Efficacy and safety of infliximab and adalimumab in <scp>C</scp>rohn's disease: a single centre study
65
Citations
34
References
2012
Year
Infliximab and adalimumab showed a similar efficacy. No smoking and non-stricturing non-penetrating behaviour were predictors of steroid-free remission.
| Year | Citations | |
|---|---|---|
Page 1
Page 1